Navigation Links


Antiretroviral at Biology News

Antiretroviral therapy may prevent excess risk of some cancers in people with HIV

In people infected with human immunodeficiency virus (HIV), highly active antiretroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new study in the March 16 issue of the Journal of the National Cancer Institute. Studies of people with acquired immunodeficiency syndrome (AIDS) have reported increased risks of several cancers, in...

Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants

Two new studies support the hypothesis that combination antiretroviral drug therapy may reduce the risk of mother-to-child HIV transmission through breastfeeding, findings that could have significant implications in the developing world. Researchers in the first study found mothers pass antiretroviral medications on to their breastfeeding infants in concentrations high enough to prevent in...

HIV mortality in India drops with introduction of generic antiretroviral therapy

The survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapy (ART), according to an article in the Nov. 15 issue of Clinical Infectious Diseases, now available online. The introduction of generic drugs into the country has encouraged people to seek HIV treatment because of the cheaper cost, the article states. Many of th...

International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), today announced that enrollment into a large international HIV/AIDS trial comparing continuous antiretroviral therapy with episodic drug treatment guided by levels of CD4+ cells has been stopped. Enrollment was stopped because those patients receiving episodic therapy had twice the...

Access to antiretrovirals unlikely to reduce HIV infection rates

A new study by Rebecca Baggaley, Neil Ferguson, and Geoff Garnett (of Imperial College London) suggests that the HIV epidemic in poor countries will not be controlled through antiretroviral drugs alone, even if universal access is achieved. As they demonstrate in an article in the open-access international medical journal PLoS Medicine, without additional prevention methods such as counseling pat...

More>>

Antiretroviral at Biology Products
Antiretroviral at Biology Technology

A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors)

In clinical research, the monitoring of protease inhibitor (PI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) antiretroviral drugs is of significant interest due to the importance of assessing inter-individual and intra-individual metabolism variability. To be of practical use, it is essential that the analytical method used to mon...
Antiretroviral at Medicine News

HIV Mortality declining in India due to Generic Antiretroviral therapy drugs

Infectious Diseases Society of America (IDSA), has reported that the survival rate of patients infected with HIV has risen dramatically due to availability of affordable generic drugs in India. //India has the second highest number of patients with HIV positive next to South Africa. In India due to availability of cheap generic drugs which has reduced the cost of Anti-retroviral therapy (ART) dru...

More effective Antiretroviral HIV drug combination

Professor Joel Gallant and his team from Johns Hopkins University School of Medicine as reported in the Journal The New England Journal of Medicine // that Antiretroviral combination drug of Tenofovir, Emtricitabine and Efavirenz is found to be effective in controlling HIV load compared to most widely used drug combination Zidovudine, Lamivudine and Efavirenz. The clinical trial calle...

AIDS Deaths On The Rise Due To Low Access To Antiretroviral Treatment

More than 570,000 children under the age of 15 die of AIDS every year - most having contacted HIV from their mothers - states a new global report highlighting concerns about the low access to antiretroviral treatment (ART).// The report by the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) shows the number of people on HIV ART in low- and midd...

Depleting stock of antiretroviral drugs in Uganda raises concern

Uganda: Come August, and Uganda will have one more problem to surmount amidst a host of crisis health issues-that of the receding stock of free antiretroviral//. Soon, Uganda will be left with zilch options to help its people who are in the grips of disease. The stock is said to be fast depleting in national referral hospitals. Many distribution set ups will not have enough to tide ov...

Antiretroviral Drugs: A Shot in the Arm to Fight Malaria?

A few of the anti-retroviral drugs in use to assist HIV infection, may aid the fight against malaria, Australian researchers said. Detailed research on existing// antiretrovirals that are already in use to combat HIV is need of the hour, which can form the basis of development of a new genre of anti-malarial drugs. This is indeed a boon to the African Population, where malaria is ramp...

More>>

Antiretroviral at Medicine Products

Nelfinavir, Antiretroviral Level, HPLC

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Saquinavir Antiretroviral Serum Level, HPLC

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
Antiretroviral at Medicine Technology
Other TagsConnectConnectConnectConnectInternalInternalSpinalSpinalSpinalSpinalAutisticSurvivorsBrazil
(Date:11/18/2008)...edure may change fertility, nutritional needs, stu...hDay News) -- Women who get pregnant after having ...and newborn complications than pregnant women who ...zed 75 studies. , Data from those studies showe...eased by 800 percent between 1998 and 2005 (from 1...
(Date:11/18/2008)...long-term didn,t prevent or curb dementia, researc...hDay News) -- Although commonly taken to improve ... biloba won,t help prevent dementia, including Alz...andardized dose of ginkgo biloba over a period of ...ntia or Alzheimer,s disease," said the study,s lea...
(Date:11/18/2008)...gic reactions, other problems have surfaced with t...Nov. 18 (HealthDay News) - American women who turn...ase wrinkles must be better informed as to the hea...o the U.S. Food and Drug Administration recommende...rged the agency to revise product labeling to warn...
(Date:11/18/2008)...Satisfaction Rate with Medicare Drug Coverage , .../ -- Ninety-two percent of seniors enrolled in the... are satisfied with their coverage according to a ...education and advocacy group for older Americans. ...ar surveys conducted over the last year found the ...
Breaking Medicine News(10 mins):Health News:Bariatric Surgery Before Pregnancy Benefits Moms, Babies 2Health News:Ginkgo No Shield Against Alzheimer's 2Health News:Ginkgo No Shield Against Alzheimer's 3Health News:Wrinkle Fillers Need Better Label Warnings: FDA Panel 2Health News:Wrinkle Fillers Need Better Label Warnings: FDA Panel 3Health News:New Survey Shows Seniors Overwhelmingly Satisfied With Medicare Part D 2
(Date:11/18/2008)...abama at Birmingham (UAB) Center for Education and...illion federal grant to study the risks and benefi... These are genetically engineered therapies that t...atoid arthritis, Crohn,s disease, psoriasis and ot... the UAB CERTs to pinpoint which biologics have po...
(Date:11/18/2008)...lay a crucial role in sustaining the biodiversity ...ntly held workshop organised by the European Scien...nt clues for protecting Europe,s rivers against a ...ate change, which are tampering with existing ecos...al forces acting upon them. , Both aquatic plan...
(Date:11/18/2008)...FG, German Research Foundation) is intensifying th...At its autumn meeting in Bonn the Grants Committee...stablishment of 13 additional Research Training Gr...ng Groups. These enable doctoral researchers to co... particularly pleased about the first Internationa...
(Date:11/17/2008)... research team has found a new gene associated wit...gene mutation was specific to a rare form of epile...s for overall epilepsy treatment. , The findings...m six different countries, appear in the Nov. 7 is..., In epilepsy, nerve cells in the brain signal ab...
Breaking Biology News(10 mins):Musculoskeletal center wins $2.2 million for drug safety 2Alpine rivers hold important clues for preserving biodiversity and coping with climate change 2Alpine rivers hold important clues for preserving biodiversity and coping with climate change 3National and international doctoral training 2National and international doctoral training 3National and international doctoral training 4National and international doctoral training 5National and international doctoral training 6National and international doctoral training 7International team discovers gene associated with epilepsy 2Nastech to Establish Subsidiary MDRNA Inc as an Independent Company to Focus on the Development of RNA Based Therapeutics 6265 1Nastech to Establish Subsidiary MDRNA Inc as an Independent Company to Focus on the Development of RNA Based Therapeutics 6265 2Nastech to Establish Subsidiary MDRNA Inc as an Independent Company to Focus on the Development of RNA Based Therapeutics 6265 3Nastech to Establish Subsidiary MDRNA Inc as an Independent Company to Focus on the Development of RNA Based Therapeutics 6265 4Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 6263 1Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 6263 2Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 6263 3Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 6263 4Roche Confirms Commencement of Due Diligence with Ventana 6261 1Roche Confirms Commencement of Due Diligence with Ventana 6261 2Roche Confirms Commencement of Due Diligence with Ventana 6261 3Roche Confirms Commencement of Due Diligence with Ventana 6261 4Sound medicine at Acoustics Meeting 6259 1Sound medicine at Acoustics Meeting 6259 2Sound medicine at Acoustics Meeting 6259 3Sound medicine at Acoustics Meeting 6259 4Sound medicine at Acoustics Meeting 6259 5Sound medicine at Acoustics Meeting 6259 6Sound medicine at Acoustics Meeting 6259 7Sound medicine at Acoustics Meeting 6259 8
Other Contentspostpostpostpostpostpostpostpostpredationpredationpreprepreprimaseextensionextensionextensionextensionextensionextensionextensionextensionextensionstreakstreak